nodes	percent_of_prediction	percent_of_DWPC	metapath
Desmopressin—PTGS2—bone cancer	0.849	1	CbGaD
Desmopressin—AVPR1B—G alpha (q) signalling events—GRM1—bone cancer	0.000855	0.0381	CbGpPWpGaD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.000765	0.0341	CbGpPWpGaD
Desmopressin—AVPR1A—G alpha (q) signalling events—GRM1—bone cancer	0.000593	0.0264	CbGpPWpGaD
Desmopressin—AVPR1B—G alpha (q) signalling events—GNA11—bone cancer	0.000551	0.0245	CbGpPWpGaD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.00053	0.0236	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR ligand binding—GRM4—bone cancer	0.000497	0.0222	CbGpPWpGaD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000493	0.0219	CbGpPWpGaD
Desmopressin—Affect lability—Epirubicin—bone cancer	0.000487	0.0038	CcSEcCtD
Desmopressin—Oedema—Cisplatin—bone cancer	0.000474	0.00369	CcSEcCtD
Desmopressin—Anaphylactic shock—Cisplatin—bone cancer	0.000474	0.00369	CcSEcCtD
Desmopressin—Infection—Cisplatin—bone cancer	0.000471	0.00367	CcSEcCtD
Desmopressin—Mood swings—Epirubicin—bone cancer	0.000469	0.00365	CcSEcCtD
Desmopressin—Nervous system disorder—Cisplatin—bone cancer	0.000465	0.00362	CcSEcCtD
Desmopressin—Tachycardia—Cisplatin—bone cancer	0.000462	0.0036	CcSEcCtD
Desmopressin—Dehydration—Epirubicin—bone cancer	0.00046	0.00359	CcSEcCtD
Desmopressin—Skin disorder—Cisplatin—bone cancer	0.00046	0.00359	CcSEcCtD
Desmopressin—Hyponatraemia—Doxorubicin—bone cancer	0.00046	0.00358	CcSEcCtD
Desmopressin—Hyperhidrosis—Cisplatin—bone cancer	0.000458	0.00357	CcSEcCtD
Desmopressin—Orthostatic hypotension—Epirubicin—bone cancer	0.000452	0.00352	CcSEcCtD
Desmopressin—Anorexia—Cisplatin—bone cancer	0.000452	0.00352	CcSEcCtD
Desmopressin—Affect lability—Doxorubicin—bone cancer	0.000451	0.00351	CcSEcCtD
Desmopressin—Hypokalaemia—Epirubicin—bone cancer	0.000451	0.00351	CcSEcCtD
Desmopressin—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000446	0.00347	CcSEcCtD
Desmopressin—Mood swings—Doxorubicin—bone cancer	0.000434	0.00338	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000432	0.00336	CcSEcCtD
Desmopressin—AVPR1B—GPCR ligand binding—GRM1—bone cancer	0.000431	0.0192	CbGpPWpGaD
Desmopressin—Abdominal distension—Epirubicin—bone cancer	0.000431	0.00336	CcSEcCtD
Desmopressin—Influenza—Epirubicin—bone cancer	0.000428	0.00333	CcSEcCtD
Desmopressin—Dehydration—Doxorubicin—bone cancer	0.000426	0.00332	CcSEcCtD
Desmopressin—Paraesthesia—Cisplatin—bone cancer	0.000425	0.00332	CcSEcCtD
Desmopressin—Upper respiratory tract infection—Methotrexate—bone cancer	0.000425	0.00331	CcSEcCtD
Desmopressin—Dyspnoea—Cisplatin—bone cancer	0.000422	0.00329	CcSEcCtD
Desmopressin—Orthostatic hypotension—Doxorubicin—bone cancer	0.000418	0.00326	CcSEcCtD
Desmopressin—Hypokalaemia—Doxorubicin—bone cancer	0.000417	0.00325	CcSEcCtD
Desmopressin—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000412	0.00321	CcSEcCtD
Desmopressin—Decreased appetite—Cisplatin—bone cancer	0.000412	0.00321	CcSEcCtD
Desmopressin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL3—bone cancer	0.00041	0.0183	CbGpPWpGaD
Desmopressin—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—bone cancer	0.00041	0.0183	CbGpPWpGaD
Desmopressin—Gastrointestinal disorder—Cisplatin—bone cancer	0.000409	0.00319	CcSEcCtD
Desmopressin—Depression—Methotrexate—bone cancer	0.000406	0.00317	CcSEcCtD
Desmopressin—Pain—Cisplatin—bone cancer	0.000405	0.00316	CcSEcCtD
Desmopressin—Abdominal distension—Doxorubicin—bone cancer	0.000399	0.00311	CcSEcCtD
Desmopressin—Upper respiratory tract infection—Epirubicin—bone cancer	0.000398	0.0031	CcSEcCtD
Desmopressin—Conjunctivitis—Methotrexate—bone cancer	0.000396	0.00309	CcSEcCtD
Desmopressin—Influenza—Doxorubicin—bone cancer	0.000396	0.00309	CcSEcCtD
Desmopressin—Sweating—Methotrexate—bone cancer	0.000391	0.00305	CcSEcCtD
Desmopressin—Feeling abnormal—Cisplatin—bone cancer	0.00039	0.00304	CcSEcCtD
Desmopressin—Weight increased—Epirubicin—bone cancer	0.000389	0.00303	CcSEcCtD
Desmopressin—Epistaxis—Methotrexate—bone cancer	0.000384	0.003	CcSEcCtD
Desmopressin—AVPR1A—G alpha (q) signalling events—GNA11—bone cancer	0.000382	0.017	CbGpPWpGaD
Desmopressin—Body temperature increased—Cisplatin—bone cancer	0.000375	0.00292	CcSEcCtD
Desmopressin—Conjunctivitis—Epirubicin—bone cancer	0.000371	0.00289	CcSEcCtD
Desmopressin—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000368	0.00287	CcSEcCtD
Desmopressin—Sweating—Epirubicin—bone cancer	0.000366	0.00285	CcSEcCtD
Desmopressin—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—bone cancer	0.000362	0.0161	CbGpPWpGaD
Desmopressin—Urinary tract disorder—Methotrexate—bone cancer	0.000361	0.00282	CcSEcCtD
Desmopressin—Weight increased—Doxorubicin—bone cancer	0.00036	0.00281	CcSEcCtD
Desmopressin—Epistaxis—Epirubicin—bone cancer	0.00036	0.0028	CcSEcCtD
Desmopressin—Urethral disorder—Methotrexate—bone cancer	0.000359	0.0028	CcSEcCtD
Desmopressin—Visual impairment—Methotrexate—bone cancer	0.000353	0.00275	CcSEcCtD
Desmopressin—Hypersensitivity—Cisplatin—bone cancer	0.000349	0.00272	CcSEcCtD
Desmopressin—AVPR1A—GPCR ligand binding—GRM4—bone cancer	0.000345	0.0154	CbGpPWpGaD
Desmopressin—Rhinitis—Epirubicin—bone cancer	0.000343	0.00268	CcSEcCtD
Desmopressin—Conjunctivitis—Doxorubicin—bone cancer	0.000343	0.00267	CcSEcCtD
Desmopressin—AVPR2—GPCR ligand binding—GRM4—bone cancer	0.000342	0.0152	CbGpPWpGaD
Desmopressin—Eye disorder—Methotrexate—bone cancer	0.000342	0.00267	CcSEcCtD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000342	0.0152	CbGpPWpGaD
Desmopressin—Asthenia—Cisplatin—bone cancer	0.00034	0.00265	CcSEcCtD
Desmopressin—Cardiac disorder—Methotrexate—bone cancer	0.00034	0.00265	CcSEcCtD
Desmopressin—Sweating—Doxorubicin—bone cancer	0.000338	0.00264	CcSEcCtD
Desmopressin—Urinary tract disorder—Epirubicin—bone cancer	0.000338	0.00264	CcSEcCtD
Desmopressin—Oedema peripheral—Epirubicin—bone cancer	0.000337	0.00263	CcSEcCtD
Desmopressin—Connective tissue disorder—Epirubicin—bone cancer	0.000337	0.00262	CcSEcCtD
Desmopressin—Urethral disorder—Epirubicin—bone cancer	0.000336	0.00262	CcSEcCtD
Desmopressin—Epistaxis—Doxorubicin—bone cancer	0.000333	0.00259	CcSEcCtD
Desmopressin—Angiopathy—Methotrexate—bone cancer	0.000332	0.00259	CcSEcCtD
Desmopressin—Immune system disorder—Methotrexate—bone cancer	0.000331	0.00258	CcSEcCtD
Desmopressin—Visual impairment—Epirubicin—bone cancer	0.00033	0.00257	CcSEcCtD
Desmopressin—Mediastinal disorder—Methotrexate—bone cancer	0.00033	0.00257	CcSEcCtD
Desmopressin—Chills—Methotrexate—bone cancer	0.000328	0.00256	CcSEcCtD
Desmopressin—Diarrhoea—Cisplatin—bone cancer	0.000324	0.00253	CcSEcCtD
Desmopressin—PTGS1—Overview of nanoparticle effects—PTGS2—bone cancer	0.000321	0.0143	CbGpPWpGaD
Desmopressin—Mental disorder—Methotrexate—bone cancer	0.000321	0.0025	CcSEcCtD
Desmopressin—Eye disorder—Epirubicin—bone cancer	0.00032	0.00249	CcSEcCtD
Desmopressin—Malnutrition—Methotrexate—bone cancer	0.000319	0.00248	CcSEcCtD
Desmopressin—Erythema—Methotrexate—bone cancer	0.000319	0.00248	CcSEcCtD
Desmopressin—Flushing—Epirubicin—bone cancer	0.000318	0.00248	CcSEcCtD
Desmopressin—Cardiac disorder—Epirubicin—bone cancer	0.000318	0.00248	CcSEcCtD
Desmopressin—Rhinitis—Doxorubicin—bone cancer	0.000318	0.00248	CcSEcCtD
Desmopressin—Urinary tract disorder—Doxorubicin—bone cancer	0.000313	0.00244	CcSEcCtD
Desmopressin—Oedema peripheral—Doxorubicin—bone cancer	0.000312	0.00243	CcSEcCtD
Desmopressin—Connective tissue disorder—Doxorubicin—bone cancer	0.000311	0.00243	CcSEcCtD
Desmopressin—Angiopathy—Epirubicin—bone cancer	0.000311	0.00242	CcSEcCtD
Desmopressin—Urethral disorder—Doxorubicin—bone cancer	0.000311	0.00242	CcSEcCtD
Desmopressin—Immune system disorder—Epirubicin—bone cancer	0.000309	0.00241	CcSEcCtD
Desmopressin—Mediastinal disorder—Epirubicin—bone cancer	0.000309	0.00241	CcSEcCtD
Desmopressin—Chills—Epirubicin—bone cancer	0.000307	0.00239	CcSEcCtD
Desmopressin—Visual impairment—Doxorubicin—bone cancer	0.000305	0.00238	CcSEcCtD
Desmopressin—AVPR1B—GPCR ligand binding—SMO—bone cancer	0.000304	0.0135	CbGpPWpGaD
Desmopressin—Vomiting—Cisplatin—bone cancer	0.000301	0.00235	CcSEcCtD
Desmopressin—Mental disorder—Epirubicin—bone cancer	0.0003	0.00234	CcSEcCtD
Desmopressin—AVPR1A—GPCR ligand binding—GRM1—bone cancer	0.000299	0.0133	CbGpPWpGaD
Desmopressin—Rash—Cisplatin—bone cancer	0.000299	0.00233	CcSEcCtD
Desmopressin—Dermatitis—Cisplatin—bone cancer	0.000298	0.00233	CcSEcCtD
Desmopressin—Erythema—Epirubicin—bone cancer	0.000298	0.00232	CcSEcCtD
Desmopressin—Malnutrition—Epirubicin—bone cancer	0.000298	0.00232	CcSEcCtD
Desmopressin—AVPR2—GPCR ligand binding—GRM1—bone cancer	0.000297	0.0132	CbGpPWpGaD
Desmopressin—Eye disorder—Doxorubicin—bone cancer	0.000296	0.00231	CcSEcCtD
Desmopressin—Ill-defined disorder—Methotrexate—bone cancer	0.000296	0.0023	CcSEcCtD
Desmopressin—Cardiac disorder—Doxorubicin—bone cancer	0.000294	0.00229	CcSEcCtD
Desmopressin—Flushing—Doxorubicin—bone cancer	0.000294	0.00229	CcSEcCtD
Desmopressin—Flatulence—Epirubicin—bone cancer	0.000294	0.00229	CcSEcCtD
Desmopressin—Tension—Epirubicin—bone cancer	0.000293	0.00228	CcSEcCtD
Desmopressin—Nervousness—Epirubicin—bone cancer	0.00029	0.00226	CcSEcCtD
Desmopressin—Angiopathy—Doxorubicin—bone cancer	0.000287	0.00224	CcSEcCtD
Desmopressin—Malaise—Methotrexate—bone cancer	0.000287	0.00224	CcSEcCtD
Desmopressin—Muscle spasms—Epirubicin—bone cancer	0.000287	0.00223	CcSEcCtD
Desmopressin—Immune system disorder—Doxorubicin—bone cancer	0.000286	0.00223	CcSEcCtD
Desmopressin—Vertigo—Methotrexate—bone cancer	0.000286	0.00223	CcSEcCtD
Desmopressin—Mediastinal disorder—Doxorubicin—bone cancer	0.000286	0.00223	CcSEcCtD
Desmopressin—Chills—Doxorubicin—bone cancer	0.000284	0.00222	CcSEcCtD
Desmopressin—AVPR2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000282	0.0126	CbGpPWpGaD
Desmopressin—Nausea—Cisplatin—bone cancer	0.000281	0.00219	CcSEcCtD
Desmopressin—AVPR1B—GPCR downstream signaling—RGS1—bone cancer	0.000281	0.0125	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR downstream signaling—GRM4—bone cancer	0.000281	0.0125	CbGpPWpGaD
Desmopressin—Cough—Methotrexate—bone cancer	0.000278	0.00217	CcSEcCtD
Desmopressin—Mental disorder—Doxorubicin—bone cancer	0.000278	0.00216	CcSEcCtD
Desmopressin—Ill-defined disorder—Epirubicin—bone cancer	0.000277	0.00216	CcSEcCtD
Desmopressin—Convulsion—Methotrexate—bone cancer	0.000276	0.00215	CcSEcCtD
Desmopressin—Malnutrition—Doxorubicin—bone cancer	0.000276	0.00215	CcSEcCtD
Desmopressin—Erythema—Doxorubicin—bone cancer	0.000276	0.00215	CcSEcCtD
Desmopressin—Agitation—Epirubicin—bone cancer	0.000274	0.00214	CcSEcCtD
Desmopressin—Flatulence—Doxorubicin—bone cancer	0.000272	0.00212	CcSEcCtD
Desmopressin—Myalgia—Methotrexate—bone cancer	0.000271	0.00211	CcSEcCtD
Desmopressin—Chest pain—Methotrexate—bone cancer	0.000271	0.00211	CcSEcCtD
Desmopressin—Tension—Doxorubicin—bone cancer	0.000271	0.00211	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000269	0.0021	CcSEcCtD
Desmopressin—Malaise—Epirubicin—bone cancer	0.000269	0.0021	CcSEcCtD
Desmopressin—Discomfort—Methotrexate—bone cancer	0.000268	0.00209	CcSEcCtD
Desmopressin—Nervousness—Doxorubicin—bone cancer	0.000268	0.00209	CcSEcCtD
Desmopressin—Vertigo—Epirubicin—bone cancer	0.000268	0.00209	CcSEcCtD
Desmopressin—Syncope—Epirubicin—bone cancer	0.000267	0.00208	CcSEcCtD
Desmopressin—PTGS1—Eicosanoid Synthesis—PTGS2—bone cancer	0.000266	0.0119	CbGpPWpGaD
Desmopressin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—bone cancer	0.000265	0.0118	CbGpPWpGaD
Desmopressin—Muscle spasms—Doxorubicin—bone cancer	0.000265	0.00207	CcSEcCtD
Desmopressin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.000264	0.0117	CbGpPWpGaD
Desmopressin—Palpitations—Epirubicin—bone cancer	0.000263	0.00205	CcSEcCtD
Desmopressin—Confusional state—Methotrexate—bone cancer	0.000262	0.00204	CcSEcCtD
Desmopressin—Loss of consciousness—Epirubicin—bone cancer	0.000262	0.00204	CcSEcCtD
Desmopressin—Cough—Epirubicin—bone cancer	0.00026	0.00203	CcSEcCtD
Desmopressin—Anaphylactic shock—Methotrexate—bone cancer	0.00026	0.00203	CcSEcCtD
Desmopressin—Convulsion—Epirubicin—bone cancer	0.000258	0.00201	CcSEcCtD
Desmopressin—Infection—Methotrexate—bone cancer	0.000258	0.00201	CcSEcCtD
Desmopressin—Hypertension—Epirubicin—bone cancer	0.000257	0.00201	CcSEcCtD
Desmopressin—Ill-defined disorder—Doxorubicin—bone cancer	0.000256	0.00199	CcSEcCtD
Desmopressin—AVPR1B—Signaling by GPCR—RGS1—bone cancer	0.000255	0.0114	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—GRM4—bone cancer	0.000255	0.0114	CbGpPWpGaD
Desmopressin—Nervous system disorder—Methotrexate—bone cancer	0.000255	0.00199	CcSEcCtD
Desmopressin—Chest pain—Epirubicin—bone cancer	0.000254	0.00198	CcSEcCtD
Desmopressin—Myalgia—Epirubicin—bone cancer	0.000254	0.00198	CcSEcCtD
Desmopressin—Agitation—Doxorubicin—bone cancer	0.000253	0.00198	CcSEcCtD
Desmopressin—Anxiety—Epirubicin—bone cancer	0.000253	0.00197	CcSEcCtD
Desmopressin—Skin disorder—Methotrexate—bone cancer	0.000253	0.00197	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000252	0.00196	CcSEcCtD
Desmopressin—Hyperhidrosis—Methotrexate—bone cancer	0.000251	0.00196	CcSEcCtD
Desmopressin—Discomfort—Epirubicin—bone cancer	0.000251	0.00195	CcSEcCtD
Desmopressin—Malaise—Doxorubicin—bone cancer	0.000249	0.00194	CcSEcCtD
Desmopressin—Vertigo—Doxorubicin—bone cancer	0.000248	0.00193	CcSEcCtD
Desmopressin—Anorexia—Methotrexate—bone cancer	0.000248	0.00193	CcSEcCtD
Desmopressin—Syncope—Doxorubicin—bone cancer	0.000247	0.00193	CcSEcCtD
Desmopressin—Confusional state—Epirubicin—bone cancer	0.000245	0.00191	CcSEcCtD
Desmopressin—Palpitations—Doxorubicin—bone cancer	0.000244	0.0019	CcSEcCtD
Desmopressin—AVPR1B—GPCR downstream signaling—GRM1—bone cancer	0.000244	0.0109	CbGpPWpGaD
Desmopressin—Oedema—Epirubicin—bone cancer	0.000243	0.0019	CcSEcCtD
Desmopressin—Anaphylactic shock—Epirubicin—bone cancer	0.000243	0.0019	CcSEcCtD
Desmopressin—AVPR2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000243	0.0108	CbGpPWpGaD
Desmopressin—Loss of consciousness—Doxorubicin—bone cancer	0.000242	0.00189	CcSEcCtD
Desmopressin—Infection—Epirubicin—bone cancer	0.000242	0.00188	CcSEcCtD
Desmopressin—Cough—Doxorubicin—bone cancer	0.000241	0.00188	CcSEcCtD
Desmopressin—Shock—Epirubicin—bone cancer	0.000239	0.00187	CcSEcCtD
Desmopressin—Convulsion—Doxorubicin—bone cancer	0.000239	0.00186	CcSEcCtD
Desmopressin—Nervous system disorder—Epirubicin—bone cancer	0.000239	0.00186	CcSEcCtD
Desmopressin—Hypertension—Doxorubicin—bone cancer	0.000238	0.00186	CcSEcCtD
Desmopressin—Tachycardia—Epirubicin—bone cancer	0.000237	0.00185	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000237	0.00185	CcSEcCtD
Desmopressin—Skin disorder—Epirubicin—bone cancer	0.000236	0.00184	CcSEcCtD
Desmopressin—Hyperhidrosis—Epirubicin—bone cancer	0.000235	0.00183	CcSEcCtD
Desmopressin—Insomnia—Methotrexate—bone cancer	0.000235	0.00183	CcSEcCtD
Desmopressin—Chest pain—Doxorubicin—bone cancer	0.000235	0.00183	CcSEcCtD
Desmopressin—Myalgia—Doxorubicin—bone cancer	0.000235	0.00183	CcSEcCtD
Desmopressin—PTGS1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000234	0.0104	CbGpPWpGaD
Desmopressin—Anxiety—Doxorubicin—bone cancer	0.000234	0.00182	CcSEcCtD
Desmopressin—Paraesthesia—Methotrexate—bone cancer	0.000233	0.00182	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000233	0.00182	CcSEcCtD
Desmopressin—Discomfort—Doxorubicin—bone cancer	0.000232	0.00181	CcSEcCtD
Desmopressin—Anorexia—Epirubicin—bone cancer	0.000232	0.00181	CcSEcCtD
Desmopressin—Dyspnoea—Methotrexate—bone cancer	0.000232	0.00181	CcSEcCtD
Desmopressin—Somnolence—Methotrexate—bone cancer	0.000231	0.0018	CcSEcCtD
Desmopressin—Dyspepsia—Methotrexate—bone cancer	0.000229	0.00178	CcSEcCtD
Desmopressin—Confusional state—Doxorubicin—bone cancer	0.000227	0.00177	CcSEcCtD
Desmopressin—Decreased appetite—Methotrexate—bone cancer	0.000226	0.00176	CcSEcCtD
Desmopressin—Anaphylactic shock—Doxorubicin—bone cancer	0.000225	0.00175	CcSEcCtD
Desmopressin—Oedema—Doxorubicin—bone cancer	0.000225	0.00175	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Methotrexate—bone cancer	0.000224	0.00175	CcSEcCtD
Desmopressin—Fatigue—Methotrexate—bone cancer	0.000224	0.00175	CcSEcCtD
Desmopressin—Infection—Doxorubicin—bone cancer	0.000224	0.00174	CcSEcCtD
Desmopressin—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—bone cancer	0.000223	0.00993	CbGpPWpGaD
Desmopressin—Pain—Methotrexate—bone cancer	0.000222	0.00173	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000222	0.00173	CcSEcCtD
Desmopressin—Shock—Doxorubicin—bone cancer	0.000221	0.00173	CcSEcCtD
Desmopressin—AVPR1B—Signaling by GPCR—GRM1—bone cancer	0.000221	0.00986	CbGpPWpGaD
Desmopressin—Nervous system disorder—Doxorubicin—bone cancer	0.000221	0.00172	CcSEcCtD
Desmopressin—Insomnia—Epirubicin—bone cancer	0.00022	0.00172	CcSEcCtD
Desmopressin—Tachycardia—Doxorubicin—bone cancer	0.00022	0.00171	CcSEcCtD
Desmopressin—Skin disorder—Doxorubicin—bone cancer	0.000219	0.0017	CcSEcCtD
Desmopressin—Paraesthesia—Epirubicin—bone cancer	0.000218	0.0017	CcSEcCtD
Desmopressin—Hyperhidrosis—Doxorubicin—bone cancer	0.000218	0.0017	CcSEcCtD
Desmopressin—Dyspnoea—Epirubicin—bone cancer	0.000217	0.00169	CcSEcCtD
Desmopressin—Somnolence—Epirubicin—bone cancer	0.000216	0.00169	CcSEcCtD
Desmopressin—Anorexia—Doxorubicin—bone cancer	0.000215	0.00167	CcSEcCtD
Desmopressin—Feeling abnormal—Methotrexate—bone cancer	0.000214	0.00167	CcSEcCtD
Desmopressin—Dyspepsia—Epirubicin—bone cancer	0.000214	0.00167	CcSEcCtD
Desmopressin—Gastrointestinal pain—Methotrexate—bone cancer	0.000213	0.00166	CcSEcCtD
Desmopressin—Decreased appetite—Epirubicin—bone cancer	0.000211	0.00165	CcSEcCtD
Desmopressin—AVPR1A—GPCR ligand binding—SMO—bone cancer	0.000211	0.00938	CbGpPWpGaD
Desmopressin—Gastrointestinal disorder—Epirubicin—bone cancer	0.00021	0.00164	CcSEcCtD
Desmopressin—Fatigue—Epirubicin—bone cancer	0.00021	0.00163	CcSEcCtD
Desmopressin—AVPR2—GPCR ligand binding—SMO—bone cancer	0.000209	0.00931	CbGpPWpGaD
Desmopressin—Constipation—Epirubicin—bone cancer	0.000208	0.00162	CcSEcCtD
Desmopressin—Pain—Epirubicin—bone cancer	0.000208	0.00162	CcSEcCtD
Desmopressin—Urticaria—Methotrexate—bone cancer	0.000207	0.00161	CcSEcCtD
Desmopressin—Abdominal pain—Methotrexate—bone cancer	0.000206	0.0016	CcSEcCtD
Desmopressin—Body temperature increased—Methotrexate—bone cancer	0.000206	0.0016	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000205	0.0016	CcSEcCtD
Desmopressin—Insomnia—Doxorubicin—bone cancer	0.000204	0.00159	CcSEcCtD
Desmopressin—Paraesthesia—Doxorubicin—bone cancer	0.000202	0.00158	CcSEcCtD
Desmopressin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.000201	0.00896	CbGpPWpGaD
Desmopressin—Dyspnoea—Doxorubicin—bone cancer	0.000201	0.00156	CcSEcCtD
Desmopressin—Feeling abnormal—Epirubicin—bone cancer	0.0002	0.00156	CcSEcCtD
Desmopressin—Somnolence—Doxorubicin—bone cancer	0.0002	0.00156	CcSEcCtD
Desmopressin—Gastrointestinal pain—Epirubicin—bone cancer	0.000199	0.00155	CcSEcCtD
Desmopressin—Dyspepsia—Doxorubicin—bone cancer	0.000198	0.00154	CcSEcCtD
Desmopressin—Decreased appetite—Doxorubicin—bone cancer	0.000196	0.00153	CcSEcCtD
Desmopressin—AVPR1A—GPCR downstream signaling—RGS1—bone cancer	0.000195	0.00868	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—GRM4—bone cancer	0.000195	0.00868	CbGpPWpGaD
Desmopressin—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000194	0.00151	CcSEcCtD
Desmopressin—Fatigue—Doxorubicin—bone cancer	0.000194	0.00151	CcSEcCtD
Desmopressin—AVPR2—GPCR downstream signaling—GRM4—bone cancer	0.000193	0.00861	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—RGS1—bone cancer	0.000193	0.00861	CbGpPWpGaD
Desmopressin—Urticaria—Epirubicin—bone cancer	0.000193	0.00151	CcSEcCtD
Desmopressin—Pain—Doxorubicin—bone cancer	0.000193	0.0015	CcSEcCtD
Desmopressin—Constipation—Doxorubicin—bone cancer	0.000193	0.0015	CcSEcCtD
Desmopressin—Abdominal pain—Epirubicin—bone cancer	0.000192	0.0015	CcSEcCtD
Desmopressin—Body temperature increased—Epirubicin—bone cancer	0.000192	0.0015	CcSEcCtD
Desmopressin—Hypersensitivity—Methotrexate—bone cancer	0.000192	0.00149	CcSEcCtD
Desmopressin—Asthenia—Methotrexate—bone cancer	0.000187	0.00145	CcSEcCtD
Desmopressin—Feeling abnormal—Doxorubicin—bone cancer	0.000186	0.00145	CcSEcCtD
Desmopressin—Gastrointestinal pain—Doxorubicin—bone cancer	0.000184	0.00143	CcSEcCtD
Desmopressin—Pruritus—Methotrexate—bone cancer	0.000184	0.00143	CcSEcCtD
Desmopressin—Hypersensitivity—Epirubicin—bone cancer	0.000179	0.0014	CcSEcCtD
Desmopressin—Urticaria—Doxorubicin—bone cancer	0.000179	0.00139	CcSEcCtD
Desmopressin—Abdominal pain—Doxorubicin—bone cancer	0.000178	0.00139	CcSEcCtD
Desmopressin—Body temperature increased—Doxorubicin—bone cancer	0.000178	0.00139	CcSEcCtD
Desmopressin—Diarrhoea—Methotrexate—bone cancer	0.000178	0.00139	CcSEcCtD
Desmopressin—AVPR1A—Signaling by GPCR—GRM4—bone cancer	0.000177	0.00788	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—RGS1—bone cancer	0.000177	0.00788	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—GRM4—bone cancer	0.000176	0.00782	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—RGS1—bone cancer	0.000176	0.00782	CbGpPWpGaD
Desmopressin—Asthenia—Epirubicin—bone cancer	0.000175	0.00136	CcSEcCtD
Desmopressin—Pruritus—Epirubicin—bone cancer	0.000172	0.00134	CcSEcCtD
Desmopressin—Dizziness—Methotrexate—bone cancer	0.000172	0.00134	CcSEcCtD
Desmopressin—AVPR1A—GPCR downstream signaling—GRM1—bone cancer	0.000169	0.00752	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—GRM1—bone cancer	0.000168	0.00747	CbGpPWpGaD
Desmopressin—Diarrhoea—Epirubicin—bone cancer	0.000166	0.0013	CcSEcCtD
Desmopressin—Hypersensitivity—Doxorubicin—bone cancer	0.000166	0.00129	CcSEcCtD
Desmopressin—Vomiting—Methotrexate—bone cancer	0.000165	0.00129	CcSEcCtD
Desmopressin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—bone cancer	0.000165	0.00733	CbGpPWpGaD
Desmopressin—Rash—Methotrexate—bone cancer	0.000164	0.00128	CcSEcCtD
Desmopressin—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—bone cancer	0.000164	0.0073	CbGpPWpGaD
Desmopressin—Dermatitis—Methotrexate—bone cancer	0.000164	0.00128	CcSEcCtD
Desmopressin—Headache—Methotrexate—bone cancer	0.000163	0.00127	CcSEcCtD
Desmopressin—Asthenia—Doxorubicin—bone cancer	0.000162	0.00126	CcSEcCtD
Desmopressin—Dizziness—Epirubicin—bone cancer	0.000161	0.00125	CcSEcCtD
Desmopressin—Pruritus—Doxorubicin—bone cancer	0.000159	0.00124	CcSEcCtD
Desmopressin—AVPR1B—GPCR downstream signaling—GNA11—bone cancer	0.000157	0.00699	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—SMO—bone cancer	0.000156	0.00694	CbGpPWpGaD
Desmopressin—Vomiting—Epirubicin—bone cancer	0.000155	0.00121	CcSEcCtD
Desmopressin—Nausea—Methotrexate—bone cancer	0.000154	0.0012	CcSEcCtD
Desmopressin—Diarrhoea—Doxorubicin—bone cancer	0.000154	0.0012	CcSEcCtD
Desmopressin—Rash—Epirubicin—bone cancer	0.000153	0.0012	CcSEcCtD
Desmopressin—AVPR1A—Signaling by GPCR—GRM1—bone cancer	0.000153	0.00683	CbGpPWpGaD
Desmopressin—Dermatitis—Epirubicin—bone cancer	0.000153	0.00119	CcSEcCtD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000153	0.00681	CbGpPWpGaD
Desmopressin—Headache—Epirubicin—bone cancer	0.000152	0.00119	CcSEcCtD
Desmopressin—AVPR2—Signaling by GPCR—GRM1—bone cancer	0.000152	0.00678	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—GRM4—bone cancer	0.000151	0.00672	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—RGS1—bone cancer	0.000151	0.00672	CbGpPWpGaD
Desmopressin—Dizziness—Doxorubicin—bone cancer	0.000149	0.00116	CcSEcCtD
Desmopressin—PTGS1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000148	0.0066	CbGpPWpGaD
Desmopressin—Nausea—Epirubicin—bone cancer	0.000145	0.00113	CcSEcCtD
Desmopressin—Vomiting—Doxorubicin—bone cancer	0.000143	0.00112	CcSEcCtD
Desmopressin—AVPR1B—Signaling by GPCR—GNA11—bone cancer	0.000143	0.00635	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR downstream signaling—IL3—bone cancer	0.000142	0.00634	CbGpPWpGaD
Desmopressin—Rash—Doxorubicin—bone cancer	0.000142	0.00111	CcSEcCtD
Desmopressin—Dermatitis—Doxorubicin—bone cancer	0.000142	0.00111	CcSEcCtD
Desmopressin—Headache—Doxorubicin—bone cancer	0.000141	0.0011	CcSEcCtD
Desmopressin—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—bone cancer	0.000141	0.00628	CbGpPWpGaD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.00014	0.00625	CbGpPWpGaD
Desmopressin—Nausea—Doxorubicin—bone cancer	0.000134	0.00104	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—GRM1—bone cancer	0.000131	0.00582	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—IL3—bone cancer	0.000129	0.00576	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000129	0.00574	CbGpPWpGaD
Desmopressin—PTGS1—Biological oxidations—CYP3A4—bone cancer	0.000124	0.00554	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00011	0.00488	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—GNA11—bone cancer	0.000109	0.00485	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—SMO—bone cancer	0.000108	0.00481	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—GNA11—bone cancer	0.000108	0.00481	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—SMO—bone cancer	0.000107	0.00478	CbGpPWpGaD
Desmopressin—PTGS1—Biological oxidations—GSTP1—bone cancer	0.000106	0.00474	CbGpPWpGaD
Desmopressin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—bone cancer	0.000106	0.00472	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—RGS1—bone cancer	0.000105	0.00465	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—GRM4—bone cancer	0.000105	0.00465	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—GRM4—bone cancer	0.000104	0.00462	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—RGS1—bone cancer	0.000104	0.00462	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—KIT—bone cancer	0.000102	0.00455	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	9.97e-05	0.00444	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—GNA11—bone cancer	9.88e-05	0.0044	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—IL3—bone cancer	9.87e-05	0.0044	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—GNA11—bone cancer	9.81e-05	0.00437	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—IL3—bone cancer	9.8e-05	0.00436	CbGpPWpGaD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	9.73e-05	0.00433	CbGpPWpGaD
Desmopressin—PTGS1—Selenium Micronutrient Network—PTGS2—bone cancer	9.42e-05	0.0042	CbGpPWpGaD
Desmopressin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	9.31e-05	0.00415	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—SMO—bone cancer	9.21e-05	0.0041	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	9.08e-05	0.00405	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—GRM1—bone cancer	9.06e-05	0.00404	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—GRM1—bone cancer	9e-05	0.00401	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—IL3—bone cancer	8.96e-05	0.00399	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	8.96e-05	0.00399	CbGpPWpGaD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	8.91e-05	0.00397	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—IL3—bone cancer	8.9e-05	0.00396	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—GNA11—bone cancer	8.42e-05	0.00375	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—CDK4—bone cancer	8.28e-05	0.00369	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—ATF1—bone cancer	7.83e-05	0.00349	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—IL3—bone cancer	7.64e-05	0.0034	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	7.59e-05	0.00338	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NDUFA12—bone cancer	7.46e-05	0.00332	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—RB1—bone cancer	7.2e-05	0.00321	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TGFBR2—bone cancer	6.53e-05	0.00291	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—SMO—bone cancer	6.38e-05	0.00284	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—SMO—bone cancer	6.34e-05	0.00282	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NT5C3A—bone cancer	6.18e-05	0.00275	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—IGF1R—bone cancer	6.15e-05	0.00274	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NDUFA12—bone cancer	5.92e-05	0.00264	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—GNA11—bone cancer	5.84e-05	0.0026	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—GNA11—bone cancer	5.8e-05	0.00258	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.63e-05	0.00251	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—ATF1—bone cancer	5.43e-05	0.00242	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—ATF1—bone cancer	5.39e-05	0.0024	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—IL3—bone cancer	5.29e-05	0.00236	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—IL3—bone cancer	5.26e-05	0.00234	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—MMP9—bone cancer	5.19e-05	0.00231	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NT5C3A—bone cancer	4.91e-05	0.00218	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TGFBR2—bone cancer	4.53e-05	0.00202	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TGFBR2—bone cancer	4.5e-05	0.002	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—KIT—bone cancer	4.46e-05	0.00199	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—IGF1R—bone cancer	4.26e-05	0.0019	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—IGF1R—bone cancer	4.23e-05	0.00188	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—EGFR—bone cancer	4.19e-05	0.00187	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—BRAF—bone cancer	4.19e-05	0.00187	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.17e-05	0.00186	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—EGFR—bone cancer	4.06e-05	0.00181	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.63e-05	0.00162	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—TP53—bone cancer	3.52e-05	0.00157	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—MDM2—bone cancer	3.51e-05	0.00156	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—KIT—bone cancer	3.09e-05	0.00138	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—KIT—bone cancer	3.07e-05	0.00137	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—JUN—bone cancer	3.05e-05	0.00136	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—MMP9—bone cancer	2.97e-05	0.00132	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—BRAF—bone cancer	2.9e-05	0.00129	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—BRAF—bone cancer	2.88e-05	0.00128	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.85e-05	0.00127	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—EGFR—bone cancer	2.81e-05	0.00125	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—EGFR—bone cancer	2.79e-05	0.00124	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ENO2—bone cancer	2.71e-05	0.00121	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ENO2—bone cancer	2.57e-05	0.00114	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—DHFR—bone cancer	2.51e-05	0.00112	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MDM2—bone cancer	2.43e-05	0.00108	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MDM2—bone cancer	2.42e-05	0.00108	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—EGFR—bone cancer	2.4e-05	0.00107	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.4e-05	0.00107	CbGpPWpGaD
Desmopressin—PTGS2—Disease—DHFR—bone cancer	2.38e-05	0.00106	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GNA11—bone cancer	2.35e-05	0.00105	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ENO2—bone cancer	2.15e-05	0.000957	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP3A4—bone cancer	2.13e-05	0.000948	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.12e-05	0.000943	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—JUN—bone cancer	2.11e-05	0.000942	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—JUN—bone cancer	2.1e-05	0.000935	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MMP9—bone cancer	2.06e-05	0.000916	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MMP9—bone cancer	2.04e-05	0.00091	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TP53—bone cancer	2.01e-05	0.000897	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—DHFR—bone cancer	1.99e-05	0.000888	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GNA11—bone cancer	1.86e-05	0.00083	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GSTP1—bone cancer	1.82e-05	0.00081	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TGFBR2—bone cancer	1.72e-05	0.000768	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP3A4—bone cancer	1.69e-05	0.000752	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—EGFR—bone cancer	1.66e-05	0.000741	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—EGFR—bone cancer	1.65e-05	0.000735	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTP1—bone cancer	1.44e-05	0.000643	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TP53—bone cancer	1.4e-05	0.000622	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TP53—bone cancer	1.39e-05	0.000617	CbGpPWpGaD
Desmopressin—PTGS2—Disease—KIT—bone cancer	1.18e-05	0.000524	CbGpPWpGaD
Desmopressin—PTGS2—Disease—BRAF—bone cancer	1.11e-05	0.000493	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PTGS2—bone cancer	9.43e-06	0.00042	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MDM2—bone cancer	9.27e-06	0.000413	CbGpPWpGaD
Desmopressin—PTGS2—Disease—EGFR—bone cancer	6.33e-06	0.000282	CbGpPWpGaD
